Literature DB >> 20071461

Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats.

Kumiko Nishihara1, Satohiro Masuda, Shunsaku Nakagawa, Atsushi Yonezawa, Takaharu Ichimura, Joseph V Bonventre, Ken-ichi Inui.   

Abstract

To clarify the specific molecular events of progressive tubular damage in chronic renal failure (CRF), we conducted microarray analyses using isolated proximal tubules from subtotally nephrectomized (Nx) rats as a model of CRF. Our results clearly demonstrated time-dependent changes in gene expression profiles localized to proximal tubules. The expression of mitosis-specific genes Cyclin B2 and Cell division cycle 2 (Cdc2) was significantly and selectively increased in the proximal tubules during the compensated period but decreased to basal level in the end-stage period. Administration of everolimus, a potent inhibitor of mammalian target of rapamycin, markedly reduced compensatory hypertrophy and hyperplasia of epithelial cells, which was accompanied by complete abolishment of the expression of Cyclin B2 and Cdc2 enhancement; renal function was then severely decreased. Treatment with the Cdc2 inhibitor 2-cyanoethyl alsterpaullone clearly decreased epithelial cell hyperplasia, based on staining of phosphorylated histone H3 and Ki-67, while hypertrophy was not inhibited. In conclusion, we have demonstrated roles of Cyclin B2 and Cdc2 in the epithelial hyperplasia in response to Nx. These results advance the knowledge of the contribution of cell cycle regulators, especially M phase, in pathophysiology of tubular restoration and/or degeneration, and these two molecules are suggested to be a marker for the proliferation of proximal tubular cells in CRF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071461      PMCID: PMC4380486          DOI: 10.1152/ajprenal.00567.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  46 in total

1.  A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats.

Authors:  T Shimamura; A B Morrison
Journal:  Am J Pathol       Date:  1975-04       Impact factor: 4.307

2.  Polar gradients of the DYRK-family kinase Pom1 couple cell length with the cell cycle.

Authors:  Sophie G Martin; Martine Berthelot-Grosjean
Journal:  Nature       Date:  2009-05-27       Impact factor: 49.962

3.  Reduced AQP1, -2, and -3 levels in kidneys of rats with CRF induced by surgical reduction in renal mass.

Authors:  T H Kwon; J Frøkiaer; M A Knepper; S Nielsen
Journal:  Am J Physiol       Date:  1998-11

4.  Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.

Authors:  Núria Lloberas; Josep M Cruzado; Marcella Franquesa; Immaculada Herrero-Fresneda; Joan Torras; Gabriela Alperovich; Inés Rama; August Vidal; Josep M Grinyó
Journal:  J Am Soc Nephrol       Date:  2006-04-05       Impact factor: 10.121

5.  Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney.

Authors:  M W Taal; K Zandi-Nejad; B Weening; A Shahsafaei; S Kato; K W Lee; F Ziai; T Jiang; B M Brenner; H S MacKenzie
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

6.  Pharmacokinetic significance of luminal multidrug and toxin extrusion 1 in chronic renal failure rats.

Authors:  Kumiko Nishihara; Satohiro Masuda; Lin Ji; Toshiya Katsura; Ken-Ichi Inui
Journal:  Biochem Pharmacol       Date:  2007-01-09       Impact factor: 5.858

7.  Gene expression variance based on random sequencing in rat remnant kidney.

Authors:  Naoshi Horiba; Satohiro Masuda; Ayako Takeuchi; Hideyuki Saito; Masahiro Okuda; Ken-Ichi Inui
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

Review 8.  Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure.

Authors:  Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

9.  Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy.

Authors:  Lin Ji; Satohiro Masuda; Hideyuki Saito; Ken-ichi Inui
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

10.  Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli.

Authors:  Hiroshi Kawachi; Hiroko Koike; Hidetake Kurihara; Tatsuo Sakai; Fujio Shimizu
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  5 in total

1.  Heterogeneous nuclear ribonucleoprotein A1 is a novel cellular target of atrial natriuretic peptide signaling in renal epithelial cells.

Authors:  Bahar Hesabi; Robert S Danziger; Kumar U Kotlo
Journal:  Cell Signal       Date:  2012-01-17       Impact factor: 4.315

2.  Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.

Authors:  Adam Whaley-Connell; Javad Habibi; Zachary Panfili; Melvin R Hayden; Sarika Bagree; Ravi Nistala; Safwan Hyder; Bennett Krueger; Vincent Demarco; Lakshmi Pulakat; Carlos M Ferrario; Alan Parrish; James R Sowers
Journal:  Am J Nephrol       Date:  2011-06-29       Impact factor: 3.754

3.  Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.

Authors:  Kumiko Nishihara; Satohiro Masuda; Haruka Shinke; Aiko Ozawa; Takaharu Ichimura; Atsushi Yonezawa; Shunsaku Nakagawa; Ken-Ichi Inui; Joseph V Bonventre; Kazuo Matsubara
Journal:  Biochem Pharmacol       Date:  2013-01-02       Impact factor: 5.858

4.  Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease.

Authors:  Shunsaku Nakagawa; Kumiko Nishihara; Hitomi Miyata; Haruka Shinke; Eri Tomita; Moto Kajiwara; Takeshi Matsubara; Noriyuki Iehara; Yoshinobu Igarashi; Hiroshi Yamada; Atsushi Fukatsu; Motoko Yanagita; Kazuo Matsubara; Satohiro Masuda
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

5.  Partial least squares based gene expression analysis in renal failure.

Authors:  Shuang Ding; Yinhai Xu; Tingting Hao; Ping Ma
Journal:  Diagn Pathol       Date:  2014-07-05       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.